368 studies found for:    Open Studies | "Duke University" [Exact]
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Duke University" [Exact]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Rejuvenated, Washed Packed Red Blood Cells in Pediatric Cardiac Surgery
Condition: Heart Defects, Congenital
Interventions: Drug: Rejuvesol;   Procedure: Cardiac surgery
2 Not yet recruiting Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Condition: Breast Cancer
Intervention: Drug: Rosuvastatin
3 Recruiting Message Framing and Colorectal Cancer Screening
Condition: Colorectal Neoplasms
Intervention: Behavioral: Educational materials
4 Not yet recruiting Study of Preoperative Boost Radiotherapy
Condition: Breast Cancer
Intervention: Radiation: Single fraction of 10Gy
5 Not yet recruiting Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Stereotactic body radiotherapy ( SBRT)
6 Not yet recruiting Addressing Real-world Anticoagulant Management Issues in Stroke
Conditions: Stroke;   Cerebrovascular Stroke;   Intracerebral Hemorrhage
Intervention:
7 Not yet recruiting A See and Treat Paradigm for Cervical Pre-cancer
Condition: Cervical Pre-cancer
Interventions: Device: transvaginal digital colposcope  (TVDC);   Other: Standard of care screening
8 Not yet recruiting SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge
Condition: Sickle Cell Disease
Intervention: Device: SMART app
9 Recruiting Predictors of Opioid-Induced Respiratory Depression (OIRD)
Condition: Respiratory Depression
Interventions: Drug: Remifentanil;   Drug: Oxygen;   Drug: Carbon dioxide
10 Not yet recruiting Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)
Condition: Peripheral Artery Disease
Interventions: Other: Fitbit Physical Activity Monitor;   Other: iHealth Glucometer;   Other: Withings Blood Pressure
11 Not yet recruiting Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot Study
Condition: Type II Diabetes
Intervention: Behavioral: Personalized Health Planning Shared Medical Appointment
12 Not yet recruiting Effect of Monitoring System Design on Response Time to Cardiac Arrhythmias
Condition: Arrhythmias, Cardiac
Intervention: Other: In-hospital cardiac monitoring method
13 Recruiting Pillars4Life Trial
Conditions: Breast Cancer;   Lung Cancer;   Esophogeal Cancer;   Colon Cancer;   Pancreatic Cancer;   Liver Cancer;   Renal Cancer;   Bladder Cancer;   Prostate Cancer
Intervention: Behavioral: Pillars4Life
14 Not yet recruiting Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)
Conditions: Fever;   Malaria
Intervention: Behavioral: Malaria RDT & conditional voucher for ACT from retail sector
15 Not yet recruiting Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Condition: Atrial Fibrillation
Intervention:
16 Not yet recruiting Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis
Conditions: Prostate Cancer;   Renal Cancer;   Brain Cancer;   ALS
Intervention:
17 Not yet recruiting Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
Condition: Neovascular Age-related Macular Degeneration
Interventions: Drug: Aflibercept;   Drug: Triamcinolone Acetonide;   Drug: Verteporfin
18 Not yet recruiting CTC Immune Checkpoint
Condition: Prostate Cancer
Intervention: Device: CTC biomarker expression prevalence
19 Recruiting Photodynamic Therapy for PDA in NV AMD
Conditions: Neovascular Age-related Macular Degeneration;   Macular Degeneration
Intervention: Other: No Intervention
20 Not yet recruiting Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT
Conditions: Myeloid Malignancies;   Lymphoid Malignancies
Interventions: Biological: NK Cell enriched-DLI only;   Biological: NK-DLI + DUK-CPG-001

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years